Sign In
Buy RKDA
$1.00
-0.0100 (-0.99%)
At Close: Jun 03, 2026
Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105%
11:26am, Monday, 09'th Dec 2024
RKDA inks deal with Roosevelt to become a new entity, Roosevelt Resources, with Roosevelt as the majority shareholder.
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Arcadia Biosciences, Inc. - RKDA
08:30pm, Friday, 06'th Dec 2024
NEW YORK , Dec. 6, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securiti
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Arcadia Biosciences, Inc.
06:19pm, Friday, 06'th Dec 2024
NEW YORK , Dec. 6, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Arcadia Biosciences, Inc. (NASDAQ: RKDA) and its board of directors concerning the prop
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Arcadia (NASDAQ: RKDA) for possible breaches of fiduciary duty and other violations of law in its transaction with Roosevelt Resources. Click her
RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. Is Fair to Shareholders
10:53am, Thursday, 05'th Dec 2024
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Arcadia Biosciences, Inc. (NASDAQ: RKDA) and Roosevelt Resources LP is fair to Arcadia
Arcadia Biosciences (RKDA) Enters Into Business Combination Agreement with Roosevelt Resources in All-Stock Transaction
08:02am, Thursday, 05'th Dec 2024
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA) and Roosevelt Resources LP announced today that they have entered into a definitive securities exchange agreement which, when comple
Arcadia Biosciences' Q3 Earnings Miss Estimates, Sales Increase Y/Y
02:06pm, Monday, 18'th Nov 2024
RKDA witnesses a solid 55% improvement in Zola sales in Q3. The company continues to invest to grow the Zola brand.
Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates
08:20pm, Tuesday, 12'th Nov 2024
Arcadia Biosciences (RKDA) came out with a quarterly loss of $0.87 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $1.83 per share a year ago.
Arcadia Biosciences, Inc. (RKDA) Q3 2024 Earnings Call Transcript
05:27pm, Tuesday, 12'th Nov 2024
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Mark Kawakami - Chief Financial Officer T.J. Schaefer - President & Chief Ex
Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call
08:30am, Tuesday, 29'th Oct 2024
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial
4 Agriculture - Products Stocks to Watch Despite Industry Concerns
02:10pm, Tuesday, 22'nd Oct 2024
The near-term outlook for the Zacks Agriculture - Products industry is uncertain due to low commodity prices and inflated costs. Investors should watch BG, WFG, HYFM and RKDA, which are braving the in
Arcadia Biosciences (RKDA) Q2 Earnings Miss, Increase Y/Y
12:06pm, Wednesday, 14'th Aug 2024
Arcadia Biosciences (RKDA) witnesses a solid 42% improvement in Zola sales in Q2. The company continues to invest to grow the Zola brand through mass market retailers and grocery store chains.
Arcadia Biosciences, Inc. (RKDA) Q2 2024 Earnings Call Transcript
08:23pm, Tuesday, 13'th Aug 2024
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q2 2024 Earnings Conference Call August 13, 2024 4:30 PM ET Company Participants Mark Kawakami - CFO T.J. Schaefer - President & CEO Conference Call Participan
Arcadia Biosciences (RKDA) Q2 Earnings Miss Estimates
06:15pm, Tuesday, 13'th Aug 2024
Arcadia Biosciences (RKDA) came out with quarterly earnings of $0.78 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to loss of $2.64 per share a year ago.
Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2024 Financial Results and Business Highlights
04:05pm, Tuesday, 13'th Aug 2024
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results
